We are dedicated to cultivating a symbiotic network that connects humanity to science for long-term positive change.
Lichen Ventures is a venture capital firm investing in climate-hard-tech companies who disrupt with discipline for the benefit of our planet. We back those with superior unit economics operating at the frontier of biomanufacturing, industrial decarbonization, adaptation and resilience, critical minerals, and methane management.
Led by managing partner Justin Brodie-Kommit, PhD, a leader in climate-hard-tech investment, Lichen Ventures and its venture partners are co-creating a symbiotic network fluent in complexity and committed to long-term impact.


Backing companies that create scalable, physical solutions with strong unit economics—delivering real-world impact and built for the planet’s next chapter.
Turning microbes into scalable solutions for sustainable fuels and biochemicals, driving growth in a $3T market and accelerating decarbonization.
Our investments enable the $14T global industry to cut emissions and improve performance, profitability, and resilience.
As billion-dollar disasters double each decade, a $1.4T market emerges for solutions that help communities thrive amid change.
Enabling secure, sustainable access to essential minerals powering the global economy.
Backing solutions that reduce methane super-pollutant emissions at scale, delivering measurable climate impact and industry transformation.
Calectra transforms heavy industry by making clean heat cheaper than fossil fuels today with their breakthrough thermal battery technology. Their drop-in solution delivers zero-carbon industrial heat up to 1600°C, addressing 25% of global energy consumption and 10% of global CO2 emissions.
![[team] image of staff member (university)](https://cdn.prod.website-files.com/68c07a45c497cdc0b87c4533/68e57ff7f2bd1d4b15ed783d_calectra-logo.png)
Aviation and petrochemicals produce 8% of global emissions. Erg Bio converts agricultural waste into cost-competitive sustainable aviation fuel, chemicals, and biomaterials using breakthrough low-cost sugar production, enabling scalable biomanufacturing.

Founder and partner testimonials